All News

Tobacco control policies decreased hospitalization for severe chest infections in children by 18%.

Exercise and a high-protein, low-glycemic diet could improve asthma symptoms by 50%.

Top news of the day from across the healthcare landscape.

Coffee drinking can cut down risk of all-cause mortality in patients with HIV and hepatitis C virus (HCV) by half, according to a 5-year study published in the Journal of Hepatology.

Janssen submits new drug application for darunavir-based, once-daily, single-tablet regimen for the treatment of HIV in adults and adolescents who are 12 years of age or older.

Concerns persist that excess folic acid supplementation may cause asthma in young children.

FDA states company sold unapproved and improperly labeled drugs that present serious public health risks, particularly sterile injectable skin whitening drug products.

A New Jersey company that sold injectable skin whitening and other beauty products has been ordered to stop selling and recall some of its products because they are unapproved new drugs that are potentially unsafe to consumers, according to the FDA's press release.

The number of sexually transmitted diseases (STDs) reported in the United States has reached a record high.

The second half of a 2-part series on the influential women shaping the specialty pharmacy industry.

Opposition to the Graham-Cassidy-Heller-Johnson amendment may sink latest effort to replace Affordable Care Act.

The Graham-Cassidy-Heller-Johnson healthcare reform package faces an uncertain fate after three GOP senators express opposition.

Same-day results increase the number of individuals who get tested and treated for HCV.

Intake of omega-3 fatty acids observed to diversify the gut microbiome.

Novel technique provides clues to differentiate progressors from non-progressors in AMD.

Sedentary behavior found to increase preference for high-fat diets and calorie consumption in rats.

Recently, experimental animal interventions have suggested that folic acid intake that exceeds the recommended dose may increase risk of respiratory disease in offspring.

The novel drug, intepirdine, was under investigation to treat patients with mild to moderate Alzheimer’s disease who were receiving donepezil therapy.

Top news of the day from across the health care landscape.

Hundreds of websites selling unapproved drugs, including opioids, antibiotics, and injectable epinephrine products.

Top news of the day from across the healthcare landscape.

FDA requests additional evidence to prove oxycodone hydrochloride extended-release tablets' abuse-deterrent potential for oral and nasal routes of administration.

As HIV becomes a disease of older Americans, health care professionals need to monitor the age-associated comorbidities among this population.

During Operation Pangea X, the FDA sent 13 warning letters to the operators of 401 websites.

Don't let stress rule your life; instead, learn how to rule stress.

Inhibiting cytokines could prevent disease progression among those with multiple sclerosis.

Healthcare workers may be at risk of chronic obstructive pulmonary disease due to exposure to cleaning products.

Draft guidance seeks to enhance equivalence testing for biosimilars.

The 15-page document offers guidance on statistical approaches to evaluating biosimilar similarity.

Officials with the FDA have rejected Intellipharmaceutics’ abuse-deterrent Oxycodone Hydrochloride Extended-Release Tablets (Rexista), the company announced in a press release.